These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
454 related items for PubMed ID: 2361473
1. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Gottschall PE, Tatsuno I, Miyata A, Arimura A. Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473 [Abstract] [Full Text] [Related]
2. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Shivers BD, Görcs TJ, Gottschall PE, Arimura A. Endocrinology; 1991 Jun; 128(6):3055-65. PubMed ID: 2036976 [Abstract] [Full Text] [Related]
3. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide. Tatsuno I, Gottschall PE, Arimura A. Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859 [Abstract] [Full Text] [Related]
4. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification. Gottschall PE, Tatsuno I, Arimura A. FASEB J; 1991 Feb; 5(2):194-9. PubMed ID: 1848519 [Abstract] [Full Text] [Related]
5. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking. Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR. J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686 [Abstract] [Full Text] [Related]
6. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB, Niewiadomski P, Nowak JZ. Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [Abstract] [Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C. Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193 [Abstract] [Full Text] [Related]
8. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ. J Mol Neurosci; 2005 Mar; 25(3):215-24. PubMed ID: 15800375 [Abstract] [Full Text] [Related]
14. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes. Ando E, Nokihara K, Naruse S, Wray V. Biomed Pept Proteins Nucleic Acids; 1996 Apr; 2(2):41-6. PubMed ID: 9346825 [Abstract] [Full Text] [Related]
15. Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung. Lam HC, Takahashi K, Ghatei MA, Kanse SM, Polak JM, Bloom SR. Eur J Biochem; 1990 Nov 13; 193(3):725-9. PubMed ID: 2249690 [Abstract] [Full Text] [Related]
16. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta. Hezareh M, Schlegel W, Rawlings SR. J Neuroendocrinol; 1996 May 13; 8(5):367-74. PubMed ID: 8736436 [Abstract] [Full Text] [Related]
17. Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes. Tatsuno I, Gottschall PE, Köves K, Arimura A. Biochem Biophys Res Commun; 1990 May 16; 168(3):1027-33. PubMed ID: 2346475 [Abstract] [Full Text] [Related]
18. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK. Endocrinology; 1998 Aug 16; 139(8):3465-79. PubMed ID: 9681497 [Abstract] [Full Text] [Related]
19. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L, Ahrén B, Edgren G, Degerman E. Endocrinology; 2005 Feb 16; 146(2):744-50. PubMed ID: 15514088 [Abstract] [Full Text] [Related]